annual EBIT:
-$3.08M+$64.44M(+95.43%)Summary
- As of today (September 14, 2025), SPRY annual earnings before interest & taxes is -$3.08 million, with the most recent change of +$64.44 million (+95.43%) on December 31, 2024.
- During the last 3 years, SPRY annual EBIT has risen by +$16.37 million (+84.15%).
- SPRY annual EBIT is now at all-time high.
Performance
SPRY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$47.61M-$10.44M(-28.07%)Summary
- As of today (September 14, 2025), SPRY quarterly earnings before interest & taxes is -$47.61 million, with the most recent change of -$10.44 million (-28.07%) on June 30, 2025.
- Over the past year, SPRY quarterly EBIT has dropped by -$32.27 million (-210.39%).
- SPRY quarterly EBIT is now -200.88% below its all-time high of $47.20 million, reached on December 31, 2024.
Performance
SPRY quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$59.34M-$32.27M(-119.23%)Summary
- As of today (September 14, 2025), SPRY TTM earnings before interest & taxes is -$59.34 million, with the most recent change of -$32.27 million (-119.23%) on June 30, 2025.
- Over the past year, SPRY TTM EBIT has dropped by -$2.61 million (-4.59%).
- SPRY TTM EBIT is now -1824.81% below its all-time high of -$3.08 million, reached on December 31, 2024.
Performance
SPRY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SPRY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +95.4% | -210.4% | -4.6% |
| 3 y3 years | +84.2% | -650.5% | +0.5% |
| 5 y5 years | +87.2% | -636.7% | -218.4% |
SPRY EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.4% | -200.9% | at low | -1824.8% | +12.1% |
| 5 y | 5-year | at high | +95.4% | -200.9% | at low | -1824.8% | +33.8% |
| alltime | all time | at high | +95.4% | -200.9% | at low | -1824.8% | +33.8% |
SPRY EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$47.61M(+28.1%) | -$59.34M(+119.2%) |
| Mar 2025 | - | -$37.18M(-178.8%) | -$27.07M(+778.0%) |
| Dec 2024 | -$3.08M(-95.4%) | $47.20M(-317.0%) | -$3.08M(-94.9%) |
| Sep 2024 | - | -$21.75M(+41.8%) | -$60.51M(+6.6%) |
| Jun 2024 | - | -$15.34M(+16.3%) | -$56.74M(-8.5%) |
| Mar 2024 | - | -$13.19M(+29.0%) | -$62.00M(-8.2%) |
| Dec 2023 | -$67.52M(+90.1%) | -$10.23M(-43.1%) | -$67.52M(+17.8%) |
| Sep 2023 | - | -$17.98M(-12.7%) | -$57.29M(+24.7%) |
| Jun 2023 | - | -$20.60M(+10.1%) | -$45.95M(+45.0%) |
| Mar 2023 | - | -$18.71M(+182.2%) | -$31.69M(-27.3%) |
| Dec 2022 | -$35.52M | - | - |
| Sep 2022 | - | -$6.63M(+4.5%) | -$43.58M(-26.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.34M(-10.6%) | -$59.63M(-23.4%) |
| Mar 2022 | - | -$7.10M(-69.8%) | -$77.80M(-13.2%) |
| Dec 2021 | -$19.45M(-40.9%) | - | - |
| Dec 2021 | - | -$23.51M(+3.6%) | -$89.58M(+13.1%) |
| Sep 2021 | - | -$22.68M(-7.5%) | -$79.18M(+40.1%) |
| Jun 2021 | - | -$24.51M(+29.8%) | -$56.50M(+46.9%) |
| Mar 2021 | - | -$18.89M(+44.1%) | -$38.45M(+55.0%) |
| Dec 2020 | -$32.92M(+36.8%) | -$13.10M(+102.7%) | -$24.81M(+33.1%) |
| Jun 2020 | - | -$6.46M(+23.3%) | -$18.64M(+53.1%) |
| Mar 2020 | - | -$5.24M(-24.4%) | -$12.17M(+75.6%) |
| Dec 2019 | -$24.07M(+31.4%) | -$6.93M | -$6.93M |
| Dec 2018 | -$18.32M | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is ARS Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of SPRY is -$3.08M
What is the all time high annual EBIT for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$3.08M
What is ARS Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, SPRY annual earnings before interest & taxes has changed by +$64.44M (+95.43%)
What is ARS Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of SPRY is -$47.61M
What is the all time high quarterly EBIT for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $47.20M
What is ARS Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, SPRY quarterly earnings before interest & taxes has changed by -$32.27M (-210.39%)
What is ARS Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of SPRY is -$59.34M
What is the all time high TTM EBIT for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$3.08M
What is ARS Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, SPRY TTM earnings before interest & taxes has changed by -$2.61M (-4.59%)